Profil bibliographique

Tetsuya Mine

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

401Publications signalées

7305Citations signalées

1Affiliations récentes

Les institutions déclarées

Les domaines associés

Pancreatic and Hepatic Oncology ResearchHelicobacter pylori-related gastroenterology studiesPancreatitis Pathology and TreatmentGastrointestinal disorders and treatmentsGallbladder and Bile Duct Disorders

Les publications récentes

Accès ouvert 2024 article OpenAlex

Therapeutic Outcome of Multidisciplinary Treatment in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Analysis

Fumi Harada, Kentaro Miyake, Ryusei Matsuyama, Kazunori Furuta et autres

jp (code pays fourni par la source)

3 citations World Journal of Oncology

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Figure Legend from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S2 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S1 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S3 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

FigureS1 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Data from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Data from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

FigureS1 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Figure Legend from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S3 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Accès ouvert 2023 other OpenAlex

Table S2 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Susumu Hijioka, Waki Hosoda, Keitaro Matsuo, Makoto Ueno et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.